ACST News and Press, Acasti Pharma Inc. From 12/23/19

Can These Stocks Continue Higher Before Friday? Over the course of the year so far, plenty of penny stocks have generated highly impressive gains for investors. As the year comes to a close, there are still some penny stocks to watch that also show impressive momentum. When it comes to th...

It’s A Short Week But These Penny Stocks Could Be On Watch Lists Starting Tomorrow The holidays are always an interesting time for the stock market, in general. However, when it comes to penny stocks , there are even more things to be aware of. First, the typical liquidity in the marke...

December 18, 2019 Palm Beach, FL – December 18, 2019 – Back in the end of 2018, a report from Moody’s said that 2019 should be a standout year for the medical device industry. They added that revenue growth for device companies would be driven through innovation...

Gainers:  Kaixin Auto (NASDAQ: KXIN ) +32% . More news on: Kaixin Auto Holdings, NantKwest, Inc., Renewable Energy Group, Inc., Stocks on the move, Read more ...

These Penny Stocks On Robinhood Rallied Last Week; Can That Continue Monday? This coming week has a lot going for it already and it isn’t even Monday yet. For those who like penny stocks , that could be a very good thing. Late last week we saw the US and China seemingly reach a Phase 1...

LAVAL, Québec, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate C...

Dover, Delaware--(Newsfile Corp. - November 25, 2019) - Encode Ideas, L.P. Initiates Research on Acasti Pharma, Inc. (NASDAQ: ACST). The full research publication is available here and available on our website at www.encodelp.com . Encode Ideas is initiating coverage on Acasti Pharma, Inc...

Introduction Our long thesis on Acasti Pharma, Inc. ( ACST ) is built on two key pillars: 1) We see significant growth in the prescription Omega 3 (Rx OM3) drug market due to the clinically proven benefits of Rx strength OM3 used for treating hypertriglyceridemia ((HTG)), and recently shown ...

Introduction Before this report, I have written two other Seeking Alpha reports about Acasti Pharma ( ACST ) in 2019, espousing ACST’s profound market opportunity and its leading drug CaPre’s competitive advantages; my first report in June was published when the stock was onl...

Oppenheimer initiates Amarin (NASDAQ: AMRN ) with an Underperform rating and $7 price target, suggesting a  whopping 70% downside  from this afternoon's close. More news on: Amarin Corporation plc, Acasti Pharma Inc., Healthcare stocks news, Stocks on the move, Quick stock ideas,...